Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Targeting Intracellular Signaling Cascades for Patients with Relapsed, Refractory Multiple Myeloma: A Systematic Review of Clinical Trials

Shehroz Aslam, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Rida Riaz, MBBS, Seren Durer, MD, Ceren Durer, MD, Faisal Mahfooz, MD, Muhammad Jahanzeb Khalil, MD, Jemin Aby Jose, MD, Zunairah Shah, MBBS, Chaudhry Saad Sohail, MD, Maaz Ahmed Yusufi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5659.

https://doi.org/10.1182/blood-2018-99-115721

Published: 2018

Journal Articles

The Use of Checkpoint Inhibitors before and after Allogeneic Stem Cell Transplantion: A Double-Edged Sword

Ali Younas Khan, MD, Awais Ijaz, MD, Muhammad Usman, MD, Muhammad Junaid Tariq, MD, Muhammad Asad Fraz, MD, Muhammad Jahanzeb Khalil, MD, Ceren Durer, MD, Seren Durer, MD, Fnu Sagar, MD, Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Zunairah Shah, MBBS, Shehroz Aslam, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5722.

https://doi.org/10.1182/blood-2018-99-110006

Published: 2018

Journal Articles

Impact of Newer Agents on Progression Free Survival of Multiple Myeloma in the 2nd 3rd and 4th Line Setting- a Systematic Review

Muhammad Sardar, MD, Jemin Aby Jose, MD, Zunairah Shah, MD, Chaudhry Saad Sohail, MD, Insija Ilyas Selene, MBBS, Madeeha Shafqat, Anum Qureshi, Raza Naseer, MD, Ali Younas Khan, MD, Saad Ullah Malik, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5645.

https://doi.org/10.1182/blood-2018-99-119662

Published: 2018

Journal Articles

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Muhammad Yasir, MD, Muhammad Junaid Tariq, MD, Arshia Akbar, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Muhammad Umair Jahngir, Ali Younas Khan, MD, Awais Ijaz, MD, Ceren Durer, MD, Seren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5559.

https://doi.org/10.1182/blood-2018-99-117084

Published: 2018

Journal Articles

Efficacy, Toxicity and Targets for Adoptive Cellular Therapy in Multiple Myeloma: A Systematic Review

Muhammad Usman, MD, Muhammad Junaid Tariq, MD, Awais Ijaz, MD, Muhammad Asad Fraz, MD, Ali Younas Khan, MD, Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Jahanzeb Khalil, MD, Arveen Asghar, Seren Durer, MD, Ceren Durer, MD, Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Mustafa Nadeem Malik, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5649.

https://doi.org/10.1182/blood-2018-99-109944

Published: 2018

Journal Articles

Role of Ibrutinib Based Regimen in Chronic Lymphocytic Leukemia

Muhammad Sardar, MD, Saad Ullah Malik, MD, Ali Younas Khan, MD, Chaudhry Saad Sohail, MD, Malik Qistas Ahmad, MD MBBS, Saher Nasir Amin, MD, Rajshekar Chakraborty, MD, Ali McBride, Muhammad Azharuddin, MD, David Sharon, Patrick Lee, MD, Warda Faridi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5563.

https://doi.org/10.1182/blood-2018-99-110257

Published: 2018

Journal Articles

Efficacy and Safety of Newer Targeted Immunotherapy for Multiple Myeloma

Shehroz Aslam, MD, Rida Riaz, MBBS, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Warda Faridi, MD, Saad Ullah Malik, MD, Insija Ilyas Selene, MBBS, Zunairah Shah, MBBS, Chaudhry Saad Sohail, MD, Faisal Mahfooz, MD, Sharoon Samuel, MBBS, Muhammad Yasir, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5650.

https://doi.org/10.1182/blood-2018-99-110233

Published: 2018

Journal Articles

Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Post-Transplant Relapsed CD19 Positive Acute Lymphoblastic Leukemia: Systematic Review

Ceren Durer, MD, Seren Durer, MD, Madeeha Shafqat, Zunairah Shah, MBBS, Maryam Sadiq, MBBS, Muhammad Asad Fraz, MD, Malik Qistas Ahmad, MD MBBS, Hafiz Muhammad Fazeel, MD, Sharoon Samuel, MBBS, Mustafa Nadeem Malik, MD, Midhat Lakhani, MD, Chaudhry Saad Sohail, MD, Anum Qureshi, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5742.

https://doi.org/10.1182/blood-2018-99-109998

Published: 2018

Journal Articles

Efficacy and Toxicity Profile of Ibrutinib Based Regimens for Refractory Multiple Myeloma: A Systematic Review

Faiza Jamil, MD, Madeeha Shafqat, Ali Younas Khan, MD, Seren Durer, MD, Ceren Durer, MD, Zunairah Shah, MBBS, Anum Qureshi, Muhammad Abu Zar, MD, Ahmad Kamal, MD, Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Insija Ilyas Selene, MBBS, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1948.

https://doi.org/10.1182/blood-2018-99-109986

Published: 2018

NARROW

Targeting Intracellular Signaling Cascades for Patients with Relapsed, Refractory Multiple Myeloma: A Systematic Review of Clinical Trials

The Use of Checkpoint Inhibitors before and after Allogeneic Stem Cell Transplantion: A Double-Edged Sword

Impact of Newer Agents on Progression Free Survival of Multiple Myeloma in the 2nd 3rd and 4th Line Setting- a Systematic Review

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Efficacy, Toxicity and Targets for Adoptive Cellular Therapy in Multiple Myeloma: A Systematic Review

Role of Ibrutinib Based Regimen in Chronic Lymphocytic Leukemia

Efficacy and Safety of Newer Targeted Immunotherapy for Multiple Myeloma

Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Post-Transplant Relapsed CD19 Positive Acute Lymphoblastic Leukemia: Systematic Review

Efficacy and Toxicity Profile of Ibrutinib Based Regimens for Refractory Multiple Myeloma: A Systematic Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only